{'fraction_non_alphanumeric': 0.02662993572084481, 'fraction_numerical': 0.0, 'mean_word_length': 5.728395061728395, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Substance use disorder in individuals with mild intellectual disabilities; collaboration needed].

BACKGROUND
Individuals with a mild intellectual disability or borderline intellectual functioning (mbid) are at risk for psychiatric disorders, including addictive disorders. Treatment of these disorders is often complicated by co-morbidity, as well as caregiver's and practitioner's struggle to effectively help. AIM: To provide guidelines for psychiatrists to organize and deliver treatment to patients with mbid and addiction. METHOD: Based on a case study, we describe obstacles in the care for patients with mbid and addiction, and provide guidelines to overcome these. RESULTS: The Netherlands are leading in providing proper care for patients with mbid and addiction. However, available treatment protocols are not widely implemented. CONCLUSION: Staff needs to be trained in working with patients with mbid and addiction, and interagency collaboration needs to be put in place. This is a collective responsibility of addiction medicine, general psychiatry, and disability services.